These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis. Denzer UW; Lüth S Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671 [TBL] [Abstract][Full Text] [Related]
5. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Castera L Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746 [TBL] [Abstract][Full Text] [Related]
6. Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology. Verveer C; de Knegt RJ Scand J Gastroenterol Suppl; 2006; (243):85-8. PubMed ID: 16782627 [TBL] [Abstract][Full Text] [Related]
7. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. McPherson S; Stewart SF; Henderson E; Burt AD; Day CP Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772 [TBL] [Abstract][Full Text] [Related]
8. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. Pagadala M; Zein CO; McCullough AJ Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307 [TBL] [Abstract][Full Text] [Related]
9. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy? Castera L; Bedossa P Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132 [TBL] [Abstract][Full Text] [Related]
10. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Adams LA; Angulo P Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970 [TBL] [Abstract][Full Text] [Related]
11. [Are non-invasive tests going to replace liver biopsy for diagnosis of liver fibrosis?]. Restellini S; Spahr L Rev Med Suisse; 2012 Jun; 8(347):1411-5. PubMed ID: 22872942 [TBL] [Abstract][Full Text] [Related]